Product Information
DOXYCYCLINE MONO 150 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.6952 per EA under NDC 64380020801. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
150 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380020801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA065070On Market Since
9/19/2022
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 150 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6952 per EA |
|---|---|
| All-time high | $1.2023 (May 14, 2025) |
| All-time low | $0.6952 (Jun 17, 2026) |
| 52-week high | $1.0039 |
| 52-week low | $0.6952 |
| Median price | $0.9511 |
| Average price | $0.9429 |
| Largest weekly change | -19.0% (May 21, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the doxycycline market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 150 MG TABLET, manufactured by Strides Pharma Inc., is $0.6952 per EA (NDC 64380020801), effective Jun 24, 2026.
How has the price of DOXYCYCLINE MONO 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has declined 38.2%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 150 MG TABLET?
Since Apr 17, 2024, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has ranged from a low of $0.6952 (Jun 17, 2026) to a high of $1.2023 (May 14, 2025), with a median of $0.9511 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DOXYCYCLINE MONO 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE MONO 150 MG TABLET?
DOXYCYCLINE MONO 150 MG TABLET (NDC 64380020801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification